1783 related articles for article (PubMed ID: 10450715)
1. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
Staessen JA; Thijs L; Fagard R; O'Brien ET; Clement D; de Leeuw PW; Mancia G; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J
JAMA; 1999 Aug; 282(6):539-46. PubMed ID: 10450715
[TBL] [Abstract][Full Text] [Related]
2. Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly.
Staessen JA; Fagard R; Thijs L; Celis H; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Fletcher AE; Babarskiene MR; Forette F; Kocemba J; Laks T; Leonetti G; Nachev C; Petrie JC; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Zanchetti A
Arch Intern Med; 1998 Aug 10-24; 158(15):1681-91. PubMed ID: 9701103
[TBL] [Abstract][Full Text] [Related]
3. Ambulatory monitoring uncorrected for placebo overestimates long-term antihypertensive action. Systolic Hypertension in Europe (SYST-EUR) Trial Investigators.
Staessen JA; Thijs L; Bieniaszewski L; O'Brien ET; Palatini P; Davidson C; Dobovisek J; Jääskivi M; Laks T; Lehtonen A; Vanhanen H; Webster J; Fagard R
Hypertension; 1996 Mar; 27(3 Pt 1):414-20. PubMed ID: 8698447
[TBL] [Abstract][Full Text] [Related]
4. Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertension.
Staessen JA; Thijs L; O'Brien ET; Bulpitt CJ; de Leeuw PW; Fagard RH; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J; Safar ME;
Am J Hypertens; 2002 Oct; 15(10 Pt 1):835-43. PubMed ID: 12372669
[TBL] [Abstract][Full Text] [Related]
5. Systolic Hypertension in Europe (Syst-Eur) trial phase 2: objectives, protocol, and initial progress. Systolic Hypertension in Europe Investigators.
Gasowski J; Staessen JA; Celis H; Fagard RH; Thijs L; Birkenhäger WH; Bulpitt CJ; Fletcher AE; Arabidze GG; de Leeuw P; Dollery CT; Duggan J; Kawecka-Jaszcz K; Leonetti G; Nachev C; Safar M; Rodico JL; Rosenfeld J; Seux ML; Tuomilehto J; Webster J; Yodfat Y
J Hum Hypertens; 1999 Feb; 13(2):135-45. PubMed ID: 10100063
[TBL] [Abstract][Full Text] [Related]
6. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
Staessen JA; Fagard R; Thijs L; Celis H; Arabidze GG; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Dollery CT; Fletcher AE; Forette F; Leonetti G; Nachev C; O'Brien ET; Rosenfeld J; Rodicio JL; Tuomilehto J; Zanchetti A
Lancet; 1997 Sep; 350(9080):757-64. PubMed ID: 9297994
[TBL] [Abstract][Full Text] [Related]
7. Calcium channel blockade and cardiovascular prognosis in the European trial on isolated systolic hypertension.
Staessen JA; Thijs L; Fagard RH; Birkenhäger WH; Arabidze G; Babeanu S; Gil-Extremera B; Bulpitt CJ; Davidson C; de Leeuw PW; Efstratopoulos AD; Fletcher AE; Fogari R; Jääskivi M; Kawecka-Jaszcz K; Nachev C; Petrie JC; Seux ML; Tuomilehto J; Webster J; Yodfat Y
Hypertension; 1998 Sep; 32(3):410-6. PubMed ID: 9740604
[TBL] [Abstract][Full Text] [Related]
8. Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes.
Yang WY; Melgarejo JD; Thijs L; Zhang ZY; Boggia J; Wei FF; Hansen TW; Asayama K; Ohkubo T; Jeppesen J; Dolan E; Stolarz-Skrzypek K; Malyutina S; Casiglia E; Lind L; Filipovský J; Maestre GE; Li Y; Wang JG; Imai Y; Kawecka-Jaszcz K; Sandoya E; Narkiewicz K; O'Brien E; Verhamme P; Staessen JA;
JAMA; 2019 Aug; 322(5):409-420. PubMed ID: 31386134
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators.
Staessen JA; Byttebier G; Buntinx F; Celis H; O'Brien ET; Fagard R
JAMA; 1997 Oct; 278(13):1065-72. PubMed ID: 9315764
[TBL] [Abstract][Full Text] [Related]
10. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
11. Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group.
Wang JG; Staessen JA; Gong L; Liu L
Arch Intern Med; 2000 Jan; 160(2):211-20. PubMed ID: 10647760
[TBL] [Abstract][Full Text] [Related]
12. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
Tuomilehto J; Rastenyte D; Birkenhäger WH; Thijs L; Antikainen R; Bulpitt CJ; Fletcher AE; Forette F; Goldhaber A; Palatini P; Sarti C; Fagard R
N Engl J Med; 1999 Mar; 340(9):677-84. PubMed ID: 10053176
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial.
Staessen JA; Den Hond E; Celis H; Fagard R; Keary L; Vandenhoven G; O'Brien ET;
JAMA; 2004 Feb; 291(8):955-64. PubMed ID: 14982911
[TBL] [Abstract][Full Text] [Related]
14. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population.
Pringle E; Phillips C; Thijs L; Davidson C; Staessen JA; de Leeuw PW; Jaaskivi M; Nachev C; Parati G; O'Brien ET; Tuomilehto J; Webster J; Bulpitt CJ; Fagard RH;
J Hypertens; 2003 Dec; 21(12):2251-7. PubMed ID: 14654744
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular Risk in Hypertension in Relation to Achieved Blood Pressure Using Automated Office Blood Pressure Measurement.
Myers MG; Kaczorowski J; Dolovich L; Tu K; Paterson JM
Hypertension; 2016 Oct; 68(4):866-72. PubMed ID: 27528062
[TBL] [Abstract][Full Text] [Related]
16. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.
Forette F; Seux ML; Staessen JA; Thijs L; Babarskiene MR; Babeanu S; Bossini A; Fagard R; Gil-Extremera B; Laks T; Kobalava Z; Sarti C; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Birkenhäger WH;
Arch Intern Med; 2002 Oct; 162(18):2046-52. PubMed ID: 12374512
[TBL] [Abstract][Full Text] [Related]
17. Dihydropyridine calcium-channel blockers for antihypertensive treatment in older patients--evidence from the Systolic Hypertension in Europe Trial.
Staessen JA; Thijs L; Celis H; Gasowski J; Wang JG; Fagard RH;
S Afr Med J; 2001 Dec; 91(12):1060-8. PubMed ID: 11845604
[TBL] [Abstract][Full Text] [Related]
18. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study.
Niiranen TJ; Hänninen MR; Johansson J; Reunanen A; Jula AM
Hypertension; 2010 Jun; 55(6):1346-51. PubMed ID: 20385970
[TBL] [Abstract][Full Text] [Related]
19. Prognostic influence of office and ambulatory blood pressures in resistant hypertension.
Salles GF; Cardoso CR; Muxfeldt ES
Arch Intern Med; 2008 Nov; 168(21):2340-6. PubMed ID: 19029499
[TBL] [Abstract][Full Text] [Related]
20. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
Shimada K; Ogihara T; Saruta T; Kuramoto K;
Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
